Journal of Psychiatry Reform
  • About us
  • How to Contribute
  • FAQ
  • Contact us
ISSN 2371-4301
Search
  • Home
  • Editorials & Commentary
  • Papers
    • Review Articles
  • Abstracts
  • Educational Programs
  • Members
  • Contact us
ARIPIPRAZOLE in DEPRESSION and ANXIETY: BUYER BEWARE!
  • January 9, 2016,
  • 0Comments

                              ALAN EPPEL MB, FRCPC Attached to the cover of a recent issue of the ..

  • Posted by Alan Eppel
  • Posted in Review Articles
ANTIDEPRESSANTS ARE COUNTERPRODUCTIVE IN BIPOLAR DISORDER
  • February 15, 2016,
  • 0Comments

ALAN EPPEL For decades, one of the most controversial issues within psychiatry has being whether or not antidepressants have any role to play in the treatment of bipolar disorder. Bipolar disorder consists of periods of depression and periods ..

  • Posted by Alan Eppel
  • Posted in Review Articles
PSYCHOTHERAPY: TOO EXPENSIVE NOT TO PROVIDE
  • April 6, 2016,
  • 0Comments

SUSAN MCNAIR MD, FRCPC I have a patient in my practice that I have being seeing weekly for several months.  Together we work through problems he has had in the past week, with coworkers or family members or with his mood.  He is incr..

  • Posted by Alan Eppel
  • Posted in Papers
The Intersection of Bullying and Mental Illness
  • September 24, 2016,
  • 0Comments

Sarah Payne MD   Bullying is a pervasive problem that affects many children and youth, especially with its extension into the cyberworld in recent years. Increasing numbers of studies have been published documenting the impact of bullying..

  • Posted by Editor JPR
  • Posted in Abstracts
Dynamic Psychotherapy Meta-analyses
  • November 13, 2016,
  • 0Comments

  This month we include two recent meta-analyses of short-term dynamic psychotherapies. The first comes from a group based in Stockholm Sweden reporting on the efficacy of Experiential Dynamic Psychotherapies- EDT. EDTs operate within the..

  • Posted by Editor JPR
  • Posted in Abstracts
BENZODIAZEPINES: THE GOOD, THE BAD, AND THE UGLY
  • November 19, 2016,
  • 0Comments

Volume 2 Number 1   Alan Eppel & Farid Ahmad   THE GOOD   Benzodiazepines and “Z-drugs”  are GABA-receptor modulators and are among  the most frequently prescribed drugs in psychiatry and primary care despite c..

  • Posted by Editor JPR
  • Posted in Papers
Prazosin First Line for PTSD
  • March 26, 2017,
  • 0Comments

Vol 2 # 5 Traitement des etats de stress post-traumatique par un antagoniste alpha-1-adrenergique, la prazosine: une revue des etudes d’evaluation. Simon P, Rousseau P. Can J Psychiatry,  62 issue: 3, 186-198 March 2017 Abstract This review..

  • Posted by Editor JPR
  • Posted in Abstracts
The 2016 CANMAT Depression Guidelines: Redefining Levels of Evidence and Levels of Funding
  • May 20, 2017,
  • 0Comments

VOL 2 #7 Natasha Snelgrove MD, FRCPC   To much fanfare, and with an entire volume of the Canadian Journal of Psychiatry dedicated to these guidelines, the fourth iteration of the Canadian Network of Mood and Anxiety Treatment (CANMAT) Guideli..

  • Posted by Editor JPR
  • Posted in Editorials & Commentary
1. Bipolar Connectivity 2. Predicting Antidepressant Response
  • May 21, 2017,
  • 0Comments

VOL 2 #7     Resting state functional connectivity in women with bipolar disorder during clinical remission.   Syan SK(1,)(2), Minuzzi L(1,)(2,)(3,)(4), Smith M(4), Allega OR(1,)(2), Hall  GB(1,)(5), Frey BN(1,)(2,)(3,)(4). &nb..

  • Posted by Editor JPR
  • Posted in Abstracts
Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood disorders: A Review.
  • July 30, 2017,
  • 0Comments

Vol 2 #9   Alan Eppel MB, FRCPC The strength of these guidelines released in 2015, is their easy readability and fluent written style coupled with numerous helpful tables and diagrams illustrating key processes. The guidelines were develo..

  • Posted by Editor JPR
  • Posted in Brief Review,Editorials & Commentary
  • 1
  • 2
  • 3
Creative Commons License
This work is licensed under a Creative Commons Attribution Non-Commercial No-Derivatives 4.0 International License.